home / stock / tffp / tffp news

TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 11/14/23

Stock Information
Company Name: TFF Pharmaceuticals Inc - Ordinary Shares
Stock Symbol: TFFP
Market: NASDAQ
Website: tffpharma.com
Menu
TFFP TFFP Quote TFFP Short TFFP News TFFP Articles TFFP Message Board
Get TFFP Alerts

News, Short Squeeze, Breakout and More Instantly...
TFFP - TFF Pharmaceuticals GAAP EPS of -$0.09 beats by $0.02, revenue of $0.23M beats by $0.13M

2023-11-14 16:21:46 ET More on TFF Pharmaceuticals Seeking Alpha’s Quant Rating on TFF Pharmaceuticals Historical earnings data for TFF Pharmaceuticals Financial information for TFF Pharmaceuticals For further details see: TFF Pharmaceuticals GAAP ...
TFFP - TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Company remains on track to report initial data from TFF VORI and TFF TAC Phase 2 trials by the end of 2023 Conference call and webcast, today Tuesday November 14, 2023, at 4:30 pm ET to provide overview of expected data readouts from ongoing Phase 2 studies FORT WORTH, Texas, Nov...

TFFP - Expected US Company Earnings on Tuesday, November 14th, 2023

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

TFFP - Expected earnings - TFF Pharmaceuticals Inc - Ordinary Shares

TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report $-0.11 for Q3 2023
TFFP - TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing

FORT WORTH, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...

TFFP - TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023

FORT WORTH, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced tha...

TFFP - TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines

FORT WORTH, Texas, Oct. 02, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, would like to congratulat...
TFFP - TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO...

TFFP - TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023

FORT WORTH, Texas, Aug. 23, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced tha...

TFFP - TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

FORT WORTH, Texas, Aug. 17, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
Previous 10 Next 10